Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial
Open Access
- 30 March 2012
- journal article
- research article
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 13 (5) , 407-414
Abstract
The objective and background is to confirm in a double-blind, placebo-controlled study the high triptan response rates we had previously reported in an open study in migraine patients with unilateral cranial autonomic symptoms. In this randomized, double-blind, placebo-controlled study 80 migraineurs with unilateral cranial autonomic symptoms were assigned to receive rizatriptan 10 mg wafer or placebo (ratio 1:1) and treated for a single moderate or severe migraine attack. The primary endpoints were pain freedom at 2 h and total migraine freedom at 2 h. Secondary endpoints included pain relief, no associated symptoms and sustained pain freedom or relief. Significantly more patients reported pain freedom at 2 h after taking rizatriptan (54 %) than after placebo (8 %) (therapeutic gain 46 % [28 %; 64 %]; P < 0.001). Similarly, significantly more patients reported total migraine freedom at 2 h after rizatriptan (51 %) than after placebo (8 %) (therapeutic gain 43 % [26 %; 61 %]; P < 0.001). Rizatriptan was also more effective than placebo on most secondary endpoints. We confirm in a placebo-controlled study our previous data suggesting that the presence of unilateral cranial autonomic symptoms in migraineurs predicts a positive response to triptans, probably owing to intense trigeminal peripheral afferent activation which strongly recruits peripheral neurovascular 5-HT1B/1D receptors. Acute and preventive pharmacological trials in migraine should focus also on this subset of migraine patients.Keywords
This publication has 16 references indexed in Scilit:
- Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study DatabaseHeadache: The Journal of Head and Face Pain, 2010
- Age Effects on Placebo Response Rates in Clinical Trials of Acute Agents for Migraine: Pooled Analysis of Rizatriptan Trials in AdultsCephalalgia, 2009
- Prevalence of Facial Pain in Migraine: A Population-Based StudyCephalalgia, 2009
- Neurobiology of migraineNeuroscience, 2009
- Prevalence of Trigeminal Autonomic Symptoms in Migraine: A Population-Based StudyCephalalgia, 2007
- Defining Response in Migraine: Which Endpoints Are Important?European Neurology, 2005
- Early Treatment of Migraine With Rizatriptan: A Placebo‐Controlled StudyHeadache: The Journal of Head and Face Pain, 2004
- The autonomic nervous system and the regulation of arterial tone in migraineClinical Autonomic Research, 1995
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990
- Migraine ‐ Cluster Headache SyndromeHeadache: The Journal of Head and Face Pain, 1985